| Bibliography
(up to 2002) |
| Selective
Reuptake Inhibitor Discontinuation Syndrome: A
Randomized Clinical Trial - Biological Psychiatry
1998; 44 pp.77-87 |
| A
comparison of the post-marketing safety of four
selective serotonin re-uptake inhibitors including
the investigation of symptoms occurring on withdrawal.Br
J Clin Pharmacol. 1996 Dec;42(6):757-63. |
| A
double-blind, randomized study to provide safety
information on switching fluoxetine-treated patients
to paroxetine without an intervening washout period.
J Clin Psychiatry. 1995 Apr;56(4):142-5. |
| A Comparison
of the post marketing safety of four Selective
Serotonin Reuptake Inhibitors including the investigation
of symptoms occurring on withdrawal - British
Journal of Clinical Pharmacology 1996 Dec; 42
(6) pp. 757-763 |
| A possible
paroxetine withdrawal syndrome.Am J Psychiatry.
1995 Apr;152(4):645-6.Phillips. |
| Adverse
Effects After the Abrupt Discontinuation of Paroxetine
- Pharmacotherapy 15 (6) pp.778-780 |
| Antidepressant
Discontinuation Reactions - British Medical Journal
1998 (316) pp.1105-1106 – 11 April |
| Antidepressant
discontinuation: a review of the literature. J
Clin Psychiatry. 1997;58 Suppl 7:11-5; discussion
16. Review. |
| Antidepressant
withdrawal syndrome. Br J Psychiatry. 1997 Mar;170:288.
No abstract available. |
Antidepressant
withdrawal syndrome. CNS Drugs. 1996;5:278-292.
Lejoyeux, Adès, Mourad, Solomon, Dilsaver. |
| Antidepressant
withdrawal syndrome.Br J Psychiatry. 1997 ar;170:288
Young, Currie, Ashton. |
| Antidepressant
Withdrawal Syndromes: Phenomenology and Pathophysiology
- International Clinical Psychopharmacology 2
p. 1-19 |
|
Antidepressant Withdrawal Syndrome:
Recognition, Prevention and Management
- CNS Drugs 1996 (5) pp. 278-292
|
| Contrasting
actions of acute or chronic paroxetine and fluvoxamine
on morphine withdrawal-induced place conditioning.
Eur J Pharmacol. 1995 Mar 6;275(2):185-9. |
| Discontinuation
of antidepressant therapy: emerging complications
and their relevance. J Clin Psychiatry. 1998 Oct;59(10):541-8.
No abstract available. |
| Discontinuation
symptoms after treatment with serotonin reuptake
inhibitors: a literature review. J Clin Psychiatry.
1997 Jul;58(7):291-7. Review. |
| Discontinuation
Symptoms and Psychotropic Drugs - Lancet 2000
v. 355 pp. 1184-1190 |
| Discontinuation
symptoms and SSRIs. J Clin Psychiatry. 1998 Oct;59(10):535-7.
No abstract available. |
| Discontinuing
antidepressants and benzodiazepines upon becoming
pregnant. Bewareof the risks of abrupt discontinuation.Can
Fam Physician. 2001 Mar;47:489-90.PMID: 11281079
[PubMed - indexed for MEDLINE] |
| Adverse
events after the abrupt discontinuation of paroxetine.
Pharmacotherapy. 1995 Nov-Dec;15(6):778-80. |
| Hormonal
markers of stress response following interruption
of selective serotonin reuptake inhibitor treatment.
Psychoneuroendocrinology. 2000 Feb;25(2):169-77. |
| Is there
a serotonergic withdrawal syndrome? Biol Psychiatry
1993;33:851-2. Mallya, White, Gunderson. |
| Lhermitte's
sign in paroxetine withdrawal. J Clin Psychopharmacol.
1996 Oct;16(5):411-2. No abstract available. |
| Medication
withdrawal symptoms in obsessive-compulsive disorder
patients treated with paroxetine. J Clin Psychopharmacol.
1994 Jun;14(3):206-7. No abstract available. |
Michelson
D, Fava M, Amsterdam J, Apter J, Londborg P, Tamura
R, Tepner RG.Interruption of selective serotonin
reuptake inhibitor treatment. Double-blind,placebo-controlled
trial.
Br J Psychiatry. 2000 Apr;176:363-8. |
| Misdiagnosis
of antidepressant discontinuation symptoms. Acta
Psychiatr Scand. 2000 Dec;102(6):466-7; discussion
467-8. PMID: 11142438 [PubMed - indexed for MEDLINE] |
| More
cases of paroxetine withdrawal syndrome. Br J
Psychiatry. 1996 Sep;169(3):384. Pacheco, Malo,
Aragues, Etxebeste. |
| Newer
antidepressants and the discontinuation syndrome.
J Clin Psychiatry. 1997;58 Suppl 7:17-21; discussion
22. Review. |
| Newer
antidepressants and the discontinuation syndrome.
J Clin Psychiatry. 1997;58(suppl 7):17-22. Haddad |
| Paroxetine
discontinuation syndrome in association with sertindole
therapy.Br J Psychiatry. 1997 Apr;170:389 Walker-Kinnear,
McNaughton. |
| Paroxetine
withdrawal syndrome Ann Med Interne (Paris). 2000
Apr;151 Suppl A:A52-3. French. PMID: 10855379
[PubMed - indexed for MEDLINE] |
| Paroxetine
withdrawal syndrome in a neonate.Br J Psychiatry.
1997 Oct;171:391-2 Dahl, Olhager, Ahlner. |
| Paroxetine
withdrawal syndrome. Am J Psychiatry. 1995 Jan;152(1):149-50
Pyke. |
| Paroxetine
withdrawal syndrome. Ann Med Interne (Paris).
2000 Apr;151 Suppl A:A52-3. Belloeuf, Le Jeunne,
Hugues. |
| Physical
symptoms associated with paroxetine discontinuation.
Am J Psychiatry. 1994 Feb;151(2):289. No abstract
available. |
| Physical
Symptoms associated with Paroxetine Withdrawal
- American Journal of Psychiatry 1995; 152 (issue
8) p. 1235 |
| Possible
biological mechanisms of the serotonin reuptake
inhibitor discontinuation syndrome. J Clin Psychiatry.
1997;58(suppl 7):23-27. Schatzberg, Haddad, Kaplan,
Lejoyeux, Rosenbaum, Young, et al. |
Postoperative
delirium indicating an adverse drug interaction
involving theselective serotonin reuptake inhibitor,
paroxetine?
J Psychopharmacol. 1999;13(3):313-7. |
Potential
withdrawal syndrome associated with SSRI discontinuation.
Ann Pharmacother. 1995;29:1284-1285. Lazowick,
Levin |
Selective
serotonin reuptake inhibitor discontinuation syndrome:
a randomized clinical trial.Biol Psychiatry. 1998
Jul 15;44(2):77-87
Rosenbaum, Fava, Hoog, Ascroft, Krebs. |
| Selective
serotonin reuptake inhibitor discontinuation syndrome:
proposed diagnostic criteria.J Psychiatry Neurosci.
2000 May;25(3):255-61.Black, Shea, Dursun, Kutcher. |
| Selective
serotonin reuptake inhibitor discontinuation syndrome:
putative mechanisms and prevention strategies.Can
J Psychiatry. 1998 Jun;43(5):523-4.Rojas-Fernandez,
Gordon. |
| Selective
serotonin reuptake inhibitor discontinuation syndrome:
putative mechanisms and prevention strategies.Can
J Psychiatry. 1999 Feb;44(1):95-6.Benazzi. |
| Serotonin
discontinuation syndrome: does it really exist?
W V Med J. 2000 Mar-Apr;96(2):405-7. Nuss, Kincaid. |
| Serotonin
reuptake inhibitor withdrawal. J Clin Psychopharmacol.
1996 Oct;16(5):356-62. |
Severe
psychiatric symptoms associated with paroxetine
withdrawal.
Lancet. 1995 Jul 1;346(8966):57. No abstract available. |
Severe
withdrawal symptoms with fever upon stopping paroxetine.
Ned Tijdschr Geneeskd. 1999 Aug 28;143(35):1795;
discussion 1795-6. Dutch. Noabstract available. |
| Shock-like
sensations after discontinuation of selective
serotonin reuptake inhibitors. Am J Psychiatry.
1995 May;152(5):810. No abstract available. |
| SSRI
Withdrawal Syndrome 1997, American Society of
Consultant Pharmacists, Inc. Skaehill, Welch |
| SSRI
withdrawal.J Clin Psychiatry. 1996 Jul;57(7):310.
No abstract available. |
The
selective serotonin reuptake inhibitor paroxetine
is effective in the
treatment of diabetic neuropathy symptoms.Pain.
1990 Aug;42(2):135-44. |
| Treatment
of disequilibrium and nausea in the SRI discontinuation
syndrome. J Clin Psychiatry. 1998 Aug;59(8):431-2.
No abstract available. |
| Unilateral
facial numbness and visual blurring associated
with paroxetine discontinuation. J Clin Psychopharmacol.
2000 Apr;20(2):271-2. No abstract available. |
| Withdrawal
after discontinuation of paroxetine. Aust N Z
J Psychiatry. 1996 Oct;30(5):702. No abstract
available. |
| Withdrawal
hypomania associated with paroxetine. J Clin Psychopharmacol.
1997 Feb;17(1):60-1. No abstract available. |
| Withdrawal
reactions with selective serotonin re-uptake inhibitors
as reported to the WHO system. Eur J Clin Pharmacol.
1997;53(3-4):163-9. |
Withdrawal
symptoms associated with paroxetine discontinuation
in a
nine-year-old boy.J Clin Psychopharmacol. 2000
Oct;20(5):586-7. No abstract available.PMID: 11001250
[PubMed - indexed for MEDLINE] |
Withdrawal
syndrome after the use of serotonin reuptake inhibitors.
Tidsskr Nor Laegeforen. 2000 Mar 20;120(8):913-4.
Norwegian. |
| Withdrawal
syndrome associated with abrupt discontinuation
of SSRIs. J Am Pharm Assoc (Wash). 1998 Jul-Aug;38(4):500-1.
No abstract available. |
| Withdrawal
syndrome caused by selective serotonin reuptake
inhibitors: apropos of a case. Schweiz Rundsch
Med Prax. 1998 Mar 4;87(10):345-8. Review. French. |
